128173-53-5((-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3-hydroxymethyl)-benzonitrile hemi D-(+)-di-p-toloyltartaric acid salt)
Product Description
128173-53-5
CAS No.
128173-53-5
Chemical Name:
(-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3-hydroxymethyl)-benzonitrile hemi D-(+)-di-p-toloyltartaric acid salt
CBNumber:
CB61503922
Molecular Formula:
2C20H23FN2O2.C20H18O8
Formula Weight:
1071.18
MOL File:
Mol file
(-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3-hydroxymethyl)-benzonitrile hemi D-(+)-di-p-toloyltartaric acid salt Synonyms:
(-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3-hydroxymethyl)-benzonitrile hemi D-(+)-di-p-toloyltartaric acid salt
(S)-4-[4-(Dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzonitrile (2S,3S)-2,3-bis[(4-methylbenzoyl)oxy]butanedioate (2:1)
Escitalopram Related Compound A (10 mg) ((-) 4-[(4-dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybutyl)]-3-(hydroxymethyl) benzonitrile)
(+)-Dipara tolouyl–d-tartaric acid salt of 4-[(4'-DiMethyl aMino)-1-(4"-fluorophenyl)-1-hydroxy butyl]-3-(hydroxy Methyl) benzonitrile
(S)-4-[4-(DiMethylaMino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxyMethyl)-benzonitrile (2S,3S)-2,3-bis[(4-Methylbenzoyl)oxy]butanedioate
EscitalopraM Related CoMpound A
Escitalopram USP Related Compound A
Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2S,3S)-, compd. with 4-[(1S)-4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzonitrile (1:2)
(-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3-hydroxymethyl)-benzonitrile hemi D-(+)-di-p-toloyltartaric acid salt
Property
Melting point:
134-135 °C
Safety
HS Code :
2926900005
(-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3-hydroxymethyl)-benzonitrile hemi D-(+)-di-p-toloyltartaric acid salt
Suppliers
Global( 74)Suppliers
China 56
India 12
United Kingdom 2
United States 4
Global 74
Supplier
Tel
Email
Country
ProdList
Advantage
Guangzhou Greensyn Co., Ltd.
luojunjian@greensyn.com
China
208
58
Nanjing Sunlida Biological Technology Co., Ltd.
025-57798810
sales@sunlidabio.com
China
3239
55
Shanghai Qiao Chemical Science Co., Ltd
021-58892003
info@qiaochem.com
China
5902
65
Nantong Hanfang Biotechnology Co. , Ltd.
hanfangpharma@126.com
China
30962
58
Hubei Qingbei Yunyan Pharmaceutical Technology Co., Ltd
18162595016;
3287908757@qq.com
China
9122
58
ANHUI WITOP BIOTECH CO., LTD
eric@witopchemical.com
China
23541
58
Henan Vcommend Consultrading Co., Ltd.
sales@vcommend.com
China
9962
58
Hangzhou Bingochem Co., Ltd.
0571-8512-5372
sales@bingochem.com
China
21669
58
128173-53-5((-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3-hydroxymethyl)-benzonitrile hemi D-(+)-di-p-toloyltartaric acid salt)
Related Search:
(-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3-hydroxymethyl)-benzonitrile hemi D-(+)-di-p-toloyltartaric acid salt
(S)-4-[4-(Dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzonitrile (2S,3S)-2,3-bis[(4-methylbenzoyl)oxy]butanedioate (2:1)
Escitalopram Related Compound A (10 mg) ((-) 4-[(4-dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybutyl)]-3-(hydroxymethyl) benzonitrile)
(+)-Dipara tolouyl–d-tartaric acid salt of 4-[(4'-DiMethyl aMino)-1-(4"-fluorophenyl)-1-hydroxy butyl]-3-(hydroxy Methyl) benzonitrile
(S)-4-[4-(DiMethylaMino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxyMethyl)-benzonitrile (2S,3S)-2,3-bis[(4-Methylbenzoyl)oxy]butanedioate
EscitalopraM Related CoMpound A
Escitalopram USP Related Compound A
Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2S,3S)-, compd. with 4-[(1S)-4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzonitrile (1:2)
(-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybutyl)-3-hydroxymethyl)-benzonitrile hemi D-(+)-di-p-toloyltartaric acid salt
Escitalopram OxalateD-DTTA
4-{4-(Dimethylamino)-[(4'-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)}benzonitrile
4-((S)-4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile D-DTTA salt
Escitalopram Related Compound A D-DTTA Salt
(2S,3S)-2,3-bis[(4-methylbenzoyl)oxy]butanedioic acid,4-[(1S)-4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzonitrile
4-[(4-Dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)-benzonitrile D-hemi tartaricacid salt
(-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3-hydroxymethyl)-benzonitrilehemiD-(+)-
(-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3...
4-[(4-Dimethylamino)-1-(4-fluorophenyl)-1-Hydroxybutyl]-3-(hydroxymethyl)-benzonitile-D-hemi tartari
(-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3-hydroxymethyl)-benzonitrile hemi D-(+)-di-p-toloyltartaric acid salt
Escitalopram Related Compound A ((S)-4-[4-dimethylamino-1-(4-fluoropheny)-1-hydroxy-1-butyl]-3-hydr (1249417)
(+)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3-hydroxymethyl)-benzonitrile hemi D-(-)-di-p-toloyltartaric acid salt
Escitalopram USP Related Compound A as Hemi-di-toluoyltartrate
Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2S,3S)-, compd. with 4-[(1S)-4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzonitrile (1:2) (9CI, ACI)
(2S,3S)-2,3-bis[(4-methylbenzoyl)oxy]-Butanedioic acid compd. with 4-[(1S)-4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzonitrile (1:2) (9CI ACI)
Benzonitrile, 4-[4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)-, (S)-, (2S,3S)-2,3-bis[(4-methylbenzoyl)oxy]butanedioate (2:1)
(‐)‐4‐(4‐Dimetylamino)‐1‐(4‐ fluorophenyl)‐1‐hydroxybutyl]‐ 3‐(hydroxymethyl)?benzonitrile? ,Hemi?D‐(+)‐Di‐p‐toluoyl?tartaric? acid?salt?(CTS‐I)
Escitalopram Oxalate EP Impurity E as (S)-Enantiomer Ditoluoyltartrate
(+)-Dipara tolouyl–d-tartaric acid salt of 4-[(4’-Dimethyl amino)-1-(4”-fluorophenyl)-1-hydroxy butyl]-3-(hydroxy methyl) benzonitrile
Escitalopram Related Compound
(S)-4-(4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile (2S,3S)-2,3-bis((4-methylbenzoyl)oxy)succinate
128173-53-5
2C20H23FN2O2C20H18O8
C60H64F2N4O12
Copyright 2017 © ChemicalBook. All rights reserved